Decreased level of osteopontin in children with allergic rhinitis during sublingual immunotherapy

Abstract Objective Sublingual immunotherapy (SLIT) is proven to be very effective in the treatment of allergic rhinitis (AR), but its regulatory mechanism and biomarkers for predicting efficacy are still unknown. Osteopontin (OPN), as a recently described Th2 inflammation related protein, plays key...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of pediatric otorhinolaryngology 2016-02, Vol.81, p.15-20
Hauptverfasser: Wang, Chunrui, Wang, Kai, Liu, Shaoting, Qin, Xiaowei, Chen, Kewa, Zhang, Tianhong
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 20
container_issue
container_start_page 15
container_title International journal of pediatric otorhinolaryngology
container_volume 81
creator Wang, Chunrui
Wang, Kai
Liu, Shaoting
Qin, Xiaowei
Chen, Kewa
Zhang, Tianhong
description Abstract Objective Sublingual immunotherapy (SLIT) is proven to be very effective in the treatment of allergic rhinitis (AR), but its regulatory mechanism and biomarkers for predicting efficacy are still unknown. Osteopontin (OPN), as a recently described Th2 inflammation related protein, plays key role in the pathogenesis of AR. The aim of this study was to identify the expression and role of OPN during SLIT in children. Methods Fifty house dust mite (HDM)-sensitized children with AR were enrolled in this study. AR children received HDM allergen extract or placebo for SLIT. Serum of different time points during treatment was collected and used for enzyme-linked immuno sorbent assay (ELISA) of OPN and related cytokines, respectively. Peripheral blood mononuclear cells from children after SLIT or placebo treatment were collected and stimulated with HDM with or without OPN/anti-OPN after one year's treatment. Results Our results showed that expression of OPN protein was decreased after one year's therapy. The decreased OPN expression was positively related to decreased Th2 cytokines and negatively related to enhanced IL-10 and TGF-β expression. In vitro experiments confirmed that children received SLIT treatment showed decreased production of Th2 cytokines by PBMCs after HDM stimulation. Conclusion During SLIT, decreased OPN expression was related to low Th2 cytokine expression and enhanced IL-10 and TGF-β expression. High serum OPN expression predicts poor treatment efficacy. OPN may be used as a biomarker for SLIT treatment.
doi_str_mv 10.1016/j.ijporl.2015.12.001
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1773900417</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0165587615006217</els_id><sourcerecordid>1760909466</sourcerecordid><originalsourceid>FETCH-LOGICAL-c450t-e2d7e34248793792e729b7ee16465b6feafa0194f6bf6914efde2c2812ef58043</originalsourceid><addsrcrecordid>eNqNkk2LFDEQhoMo7rj6D0Ry9NJtkslH90WQ9WMXFjyo55BOV3bSppM26V6Zf2-GWT14USioy1NV8LyF0EtKWkqofDO1flpSDi0jVLSUtYTQR2hHO8Wajkv-GO0qJhrRKXmBnpUyVUARIZ6iCyY7SljHdsi8B5vBFBhxgHsIODmcygppSXH1EdeyBx_GDBH_9OsBmxAg33mL88FHv_qCxy37eIfLNoTaNxOwn-ctpvUA2SzH5-iJM6HAi4d-ib59_PD16rq5_fzp5urdbWO5IGsDbFSw54x3qt-rnoFi_aAAqORSDNKBcYbQnjs5ONlTDm4EZllHGTjREb6_RK_Pe5ecfmxQVj37YiEEEyFtRVOl9j0hnKr_QCXpSc-lrCg_ozanUjI4vWQ_m3zUlOhTDnrS5xz0KQdNma6a69irhwvbMMP4Z-i3-Aq8PQNQldx7yLpYD9HC6DPYVY_J_-vC3wts1e-tCd_hCGVKW45Vt6a61AH95fQLp1egghDJqoRfQ_uxLg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1760909466</pqid></control><display><type>article</type><title>Decreased level of osteopontin in children with allergic rhinitis during sublingual immunotherapy</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Wang, Chunrui ; Wang, Kai ; Liu, Shaoting ; Qin, Xiaowei ; Chen, Kewa ; Zhang, Tianhong</creator><creatorcontrib>Wang, Chunrui ; Wang, Kai ; Liu, Shaoting ; Qin, Xiaowei ; Chen, Kewa ; Zhang, Tianhong</creatorcontrib><description>Abstract Objective Sublingual immunotherapy (SLIT) is proven to be very effective in the treatment of allergic rhinitis (AR), but its regulatory mechanism and biomarkers for predicting efficacy are still unknown. Osteopontin (OPN), as a recently described Th2 inflammation related protein, plays key role in the pathogenesis of AR. The aim of this study was to identify the expression and role of OPN during SLIT in children. Methods Fifty house dust mite (HDM)-sensitized children with AR were enrolled in this study. AR children received HDM allergen extract or placebo for SLIT. Serum of different time points during treatment was collected and used for enzyme-linked immuno sorbent assay (ELISA) of OPN and related cytokines, respectively. Peripheral blood mononuclear cells from children after SLIT or placebo treatment were collected and stimulated with HDM with or without OPN/anti-OPN after one year's treatment. Results Our results showed that expression of OPN protein was decreased after one year's therapy. The decreased OPN expression was positively related to decreased Th2 cytokines and negatively related to enhanced IL-10 and TGF-β expression. In vitro experiments confirmed that children received SLIT treatment showed decreased production of Th2 cytokines by PBMCs after HDM stimulation. Conclusion During SLIT, decreased OPN expression was related to low Th2 cytokine expression and enhanced IL-10 and TGF-β expression. High serum OPN expression predicts poor treatment efficacy. OPN may be used as a biomarker for SLIT treatment.</description><identifier>ISSN: 0165-5876</identifier><identifier>EISSN: 1872-8464</identifier><identifier>DOI: 10.1016/j.ijporl.2015.12.001</identifier><identifier>PMID: 26810282</identifier><language>eng</language><publisher>Ireland: Elsevier Ireland Ltd</publisher><subject>Adolescent ; Allergens - immunology ; Allergic rhinitis ; Animals ; Biomarkers - blood ; Child ; Child, Preschool ; Cytokines - metabolism ; Dermatophagoides pteronyssinus ; Enzyme-Linked Immunosorbent Assay ; Female ; Humans ; Leukocytes, Mononuclear - drug effects ; Leukocytes, Mononuclear - immunology ; Male ; Osteopontin ; Osteopontin - blood ; Otolaryngology ; Pediatrics ; Pyroglyphidae - immunology ; Rhinitis, Allergic - drug therapy ; Rhinitis, Allergic - immunology ; Sublingual immunotherapy ; Sublingual Immunotherapy - methods ; Th2 cytokines ; Treatment Outcome</subject><ispartof>International journal of pediatric otorhinolaryngology, 2016-02, Vol.81, p.15-20</ispartof><rights>Elsevier Ireland Ltd</rights><rights>2015 Elsevier Ireland Ltd</rights><rights>Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c450t-e2d7e34248793792e729b7ee16465b6feafa0194f6bf6914efde2c2812ef58043</citedby><cites>FETCH-LOGICAL-c450t-e2d7e34248793792e729b7ee16465b6feafa0194f6bf6914efde2c2812ef58043</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ijporl.2015.12.001$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26810282$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Chunrui</creatorcontrib><creatorcontrib>Wang, Kai</creatorcontrib><creatorcontrib>Liu, Shaoting</creatorcontrib><creatorcontrib>Qin, Xiaowei</creatorcontrib><creatorcontrib>Chen, Kewa</creatorcontrib><creatorcontrib>Zhang, Tianhong</creatorcontrib><title>Decreased level of osteopontin in children with allergic rhinitis during sublingual immunotherapy</title><title>International journal of pediatric otorhinolaryngology</title><addtitle>Int J Pediatr Otorhinolaryngol</addtitle><description>Abstract Objective Sublingual immunotherapy (SLIT) is proven to be very effective in the treatment of allergic rhinitis (AR), but its regulatory mechanism and biomarkers for predicting efficacy are still unknown. Osteopontin (OPN), as a recently described Th2 inflammation related protein, plays key role in the pathogenesis of AR. The aim of this study was to identify the expression and role of OPN during SLIT in children. Methods Fifty house dust mite (HDM)-sensitized children with AR were enrolled in this study. AR children received HDM allergen extract or placebo for SLIT. Serum of different time points during treatment was collected and used for enzyme-linked immuno sorbent assay (ELISA) of OPN and related cytokines, respectively. Peripheral blood mononuclear cells from children after SLIT or placebo treatment were collected and stimulated with HDM with or without OPN/anti-OPN after one year's treatment. Results Our results showed that expression of OPN protein was decreased after one year's therapy. The decreased OPN expression was positively related to decreased Th2 cytokines and negatively related to enhanced IL-10 and TGF-β expression. In vitro experiments confirmed that children received SLIT treatment showed decreased production of Th2 cytokines by PBMCs after HDM stimulation. Conclusion During SLIT, decreased OPN expression was related to low Th2 cytokine expression and enhanced IL-10 and TGF-β expression. High serum OPN expression predicts poor treatment efficacy. OPN may be used as a biomarker for SLIT treatment.</description><subject>Adolescent</subject><subject>Allergens - immunology</subject><subject>Allergic rhinitis</subject><subject>Animals</subject><subject>Biomarkers - blood</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Cytokines - metabolism</subject><subject>Dermatophagoides pteronyssinus</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Female</subject><subject>Humans</subject><subject>Leukocytes, Mononuclear - drug effects</subject><subject>Leukocytes, Mononuclear - immunology</subject><subject>Male</subject><subject>Osteopontin</subject><subject>Osteopontin - blood</subject><subject>Otolaryngology</subject><subject>Pediatrics</subject><subject>Pyroglyphidae - immunology</subject><subject>Rhinitis, Allergic - drug therapy</subject><subject>Rhinitis, Allergic - immunology</subject><subject>Sublingual immunotherapy</subject><subject>Sublingual Immunotherapy - methods</subject><subject>Th2 cytokines</subject><subject>Treatment Outcome</subject><issn>0165-5876</issn><issn>1872-8464</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkk2LFDEQhoMo7rj6D0Ry9NJtkslH90WQ9WMXFjyo55BOV3bSppM26V6Zf2-GWT14USioy1NV8LyF0EtKWkqofDO1flpSDi0jVLSUtYTQR2hHO8Wajkv-GO0qJhrRKXmBnpUyVUARIZ6iCyY7SljHdsi8B5vBFBhxgHsIODmcygppSXH1EdeyBx_GDBH_9OsBmxAg33mL88FHv_qCxy37eIfLNoTaNxOwn-ctpvUA2SzH5-iJM6HAi4d-ib59_PD16rq5_fzp5urdbWO5IGsDbFSw54x3qt-rnoFi_aAAqORSDNKBcYbQnjs5ONlTDm4EZllHGTjREb6_RK_Pe5ecfmxQVj37YiEEEyFtRVOl9j0hnKr_QCXpSc-lrCg_ozanUjI4vWQ_m3zUlOhTDnrS5xz0KQdNma6a69irhwvbMMP4Z-i3-Aq8PQNQldx7yLpYD9HC6DPYVY_J_-vC3wts1e-tCd_hCGVKW45Vt6a61AH95fQLp1egghDJqoRfQ_uxLg</recordid><startdate>20160201</startdate><enddate>20160201</enddate><creator>Wang, Chunrui</creator><creator>Wang, Kai</creator><creator>Liu, Shaoting</creator><creator>Qin, Xiaowei</creator><creator>Chen, Kewa</creator><creator>Zhang, Tianhong</creator><general>Elsevier Ireland Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>20160201</creationdate><title>Decreased level of osteopontin in children with allergic rhinitis during sublingual immunotherapy</title><author>Wang, Chunrui ; Wang, Kai ; Liu, Shaoting ; Qin, Xiaowei ; Chen, Kewa ; Zhang, Tianhong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c450t-e2d7e34248793792e729b7ee16465b6feafa0194f6bf6914efde2c2812ef58043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adolescent</topic><topic>Allergens - immunology</topic><topic>Allergic rhinitis</topic><topic>Animals</topic><topic>Biomarkers - blood</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Cytokines - metabolism</topic><topic>Dermatophagoides pteronyssinus</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Female</topic><topic>Humans</topic><topic>Leukocytes, Mononuclear - drug effects</topic><topic>Leukocytes, Mononuclear - immunology</topic><topic>Male</topic><topic>Osteopontin</topic><topic>Osteopontin - blood</topic><topic>Otolaryngology</topic><topic>Pediatrics</topic><topic>Pyroglyphidae - immunology</topic><topic>Rhinitis, Allergic - drug therapy</topic><topic>Rhinitis, Allergic - immunology</topic><topic>Sublingual immunotherapy</topic><topic>Sublingual Immunotherapy - methods</topic><topic>Th2 cytokines</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Chunrui</creatorcontrib><creatorcontrib>Wang, Kai</creatorcontrib><creatorcontrib>Liu, Shaoting</creatorcontrib><creatorcontrib>Qin, Xiaowei</creatorcontrib><creatorcontrib>Chen, Kewa</creatorcontrib><creatorcontrib>Zhang, Tianhong</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>International journal of pediatric otorhinolaryngology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Chunrui</au><au>Wang, Kai</au><au>Liu, Shaoting</au><au>Qin, Xiaowei</au><au>Chen, Kewa</au><au>Zhang, Tianhong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Decreased level of osteopontin in children with allergic rhinitis during sublingual immunotherapy</atitle><jtitle>International journal of pediatric otorhinolaryngology</jtitle><addtitle>Int J Pediatr Otorhinolaryngol</addtitle><date>2016-02-01</date><risdate>2016</risdate><volume>81</volume><spage>15</spage><epage>20</epage><pages>15-20</pages><issn>0165-5876</issn><eissn>1872-8464</eissn><abstract>Abstract Objective Sublingual immunotherapy (SLIT) is proven to be very effective in the treatment of allergic rhinitis (AR), but its regulatory mechanism and biomarkers for predicting efficacy are still unknown. Osteopontin (OPN), as a recently described Th2 inflammation related protein, plays key role in the pathogenesis of AR. The aim of this study was to identify the expression and role of OPN during SLIT in children. Methods Fifty house dust mite (HDM)-sensitized children with AR were enrolled in this study. AR children received HDM allergen extract or placebo for SLIT. Serum of different time points during treatment was collected and used for enzyme-linked immuno sorbent assay (ELISA) of OPN and related cytokines, respectively. Peripheral blood mononuclear cells from children after SLIT or placebo treatment were collected and stimulated with HDM with or without OPN/anti-OPN after one year's treatment. Results Our results showed that expression of OPN protein was decreased after one year's therapy. The decreased OPN expression was positively related to decreased Th2 cytokines and negatively related to enhanced IL-10 and TGF-β expression. In vitro experiments confirmed that children received SLIT treatment showed decreased production of Th2 cytokines by PBMCs after HDM stimulation. Conclusion During SLIT, decreased OPN expression was related to low Th2 cytokine expression and enhanced IL-10 and TGF-β expression. High serum OPN expression predicts poor treatment efficacy. OPN may be used as a biomarker for SLIT treatment.</abstract><cop>Ireland</cop><pub>Elsevier Ireland Ltd</pub><pmid>26810282</pmid><doi>10.1016/j.ijporl.2015.12.001</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0165-5876
ispartof International journal of pediatric otorhinolaryngology, 2016-02, Vol.81, p.15-20
issn 0165-5876
1872-8464
language eng
recordid cdi_proquest_miscellaneous_1773900417
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Adolescent
Allergens - immunology
Allergic rhinitis
Animals
Biomarkers - blood
Child
Child, Preschool
Cytokines - metabolism
Dermatophagoides pteronyssinus
Enzyme-Linked Immunosorbent Assay
Female
Humans
Leukocytes, Mononuclear - drug effects
Leukocytes, Mononuclear - immunology
Male
Osteopontin
Osteopontin - blood
Otolaryngology
Pediatrics
Pyroglyphidae - immunology
Rhinitis, Allergic - drug therapy
Rhinitis, Allergic - immunology
Sublingual immunotherapy
Sublingual Immunotherapy - methods
Th2 cytokines
Treatment Outcome
title Decreased level of osteopontin in children with allergic rhinitis during sublingual immunotherapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T08%3A46%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Decreased%20level%20of%20osteopontin%20in%20children%20with%20allergic%20rhinitis%20during%20sublingual%20immunotherapy&rft.jtitle=International%20journal%20of%20pediatric%20otorhinolaryngology&rft.au=Wang,%20Chunrui&rft.date=2016-02-01&rft.volume=81&rft.spage=15&rft.epage=20&rft.pages=15-20&rft.issn=0165-5876&rft.eissn=1872-8464&rft_id=info:doi/10.1016/j.ijporl.2015.12.001&rft_dat=%3Cproquest_cross%3E1760909466%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1760909466&rft_id=info:pmid/26810282&rft_els_id=S0165587615006217&rfr_iscdi=true